Jubilant Ingrevia has received approval for raising of funds up to Rs 600 crore by issuance of Commercial Paper (CP). The members of the Finance Committee, at its meeting held on August 18, 2023 has considered and approved the same.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| BASF India | 3865.25 |
| Tata Chemicals | 761.95 |
| SRF | 2798.45 |
| Pidilite Inds. | 1436.40 |
| Deepak Nitrite | 1861.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: